Effectiveness of Exparel TAP Block in Breast Free Flap Reconstruction

PHASE4CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

December 28, 2022

Study Completion Date

December 28, 2022

Conditions
Postoperative PainBreast Reconstruction
Interventions
DRUG

Liposomal bupivacaine TAP block

Group will receive Liposomal bupivacaine TAP block (mixed with plain bupivacaine) intraoperatively during free flap breast reconstruction as part of the multimodal pain control.

DRUG

Bupivacain

Group will receive plain bupivacaine TAP block intraoperatively during free flap breast reconstruction as part of the multimodal pain control.

Trial Locations (2)

22902

University of Virginia Medical Center, Charlottesville

22903

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT04777591 - Effectiveness of Exparel TAP Block in Breast Free Flap Reconstruction | Biotech Hunter | Biotech Hunter